Thymoctonan

Thymoctonan

SCHEMBL15532000

CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)[C@@H](N)CC(C)C)C(=O)O

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ REN P00797 1/20 0.52
▸ CALCRL Q16602 2/20 0.52
▸ RAMP1 O60894 1/20 0.52
▸ OPRK1 P41145 2/20 0.52
▸ OPRD1 P41143 4/20 0.52
▸ F2 P00734 1/20 0.52
▸ OPRM1 P35372 2/20 0.51
▸ ACE P12821 1/20 0.50
▸ KEAP1 Q14145 1/20 0.50
▸ NTSR2 O95665 1/20 0.49
▸ NTSR1 P30989 1/20 0.49
▸ SORT1 Q99523 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thymoctonan SCHEMBL1230532 1.00 REN (0.52) RENCALCRLRAMP1OPRK1OPRD1
SCHEMBL30259604 0.97 REN (0.53) RENCALCRLRAMP1OPRK1OPRD1
SCHEMBL2195454 0.93 OPRD1 (0.55) RENOPRK1OPRD1F2ACE
SCHEMBL31323239 0.93 CALCRL (0.56) CALCRLRAMP1OPRD1F2OPRM1
SCHEMBL17456231 0.93 REN (0.51) RENCALCRLRAMP1OPRK1OPRD1
SCHEMBL30011888 0.91 OPRM1 (0.55) RENOPRK1OPRM1KEAP1
SCHEMBL30603858 0.90 CALCRL (0.53) CALCRLRAMP1OPRD1F2KEAP1
SCHEMBL31694408 0.90 F2 (0.58) CALCRLRAMP1OPRK1OPRD1F2
SCHEMBL30469507 0.88 F2 (0.56) CALCRLRAMP1OPRK1OPRD1F2
SCHEMBL29666135 0.86 OPRK1 (0.58) RENOPRK1OPRD1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2846788-A1 USE OF COMPOUNDS FOR THE TREATMENT OF PAIN Akron Molecules AG (AT) 2015-03-18 — — EP disclosed
WO-2013167743-A1 USE OF COMPOUNDS FOR THE TREATMENT OF PAIN AKRON MOLECULES GMBH (AT) 2013-11-14 — — WO disclosed
Send feedback